Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Tetrahydrofuran | HCID 8028 | — |
| Reactant | 1H-1,2,4-Triazole, 1-methyl- | HCID 22459 | — |
| Reactant | 3-(5-Bromo-3-methyl-thiophen-2-yl)-8-(1-ethyl-propyl)-2,6-dimethyl-imidazo[1,2-b]pyridazine | HCID 57932943 | — |
| Reactant | Butyllithium | HCID 178418339 | — |
| Catalyst | Zincchloride | HCID 3007855 | — |
| Catalyst | Bis(cyclopenta-1,4-dien-1-yl(diphenyl)phosphane);dichloropalladium;iron(2+) | HCID 178418228 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Product | HCID 57932934 | HCID 57932934 | 60% |
Reaction Steps
To a −78° C. solution of 1-methyl-1,2,4-triazole (0.15 mL, 2.04 mmol) and THF (3 mL) is added a 1.34 M solution of n-Bu-Li in hexanes (1.60 mL, 2.14 mmol) over 20 minutes, then stirred at −78° C. for 1.5 hours. A 0.5 M solution of ZnCl2 in THF (4.28 mL, 2.14 mmol) is added and the solution warmed to ambient temperature. 3-(5-Bromo-3-methyl-thiophen-2-yl)-8-(1-ethyl-propyl)-2,6-dimethyl-imidazo[1,2-b]pyridazine (0.40 g, 1.019 mmol) and PdCl2(dppf) (0.037 g, 0.051 mmol) is added and the solution heated at 65° C. overnight diluted with CH2Cl2 (30 mL). The organic layer is washed with 10% citric acid (20 mL), water (20 mL), brine (20 mL), dried over MgSO4, filtered and concentrated. The residue is purified by ISCO (20%-60% EtOAc/hexane gradient). The residue is dissolved in Et2O, treated with Darco®-60 for 15 minutes, dried with Na2SO4, and filtered to furnish the title compound (0.24 g, 0.61 mmol, 60%). 1H NMR (CDCl3), δ 0.88 (t, J=7.4 Hz, 6H), 1.75-1.93 (m, 4H), 2.20 (s, 3H), 2.50 (s, 3H), 2.51 (s, 3H), 3.28-3.37 (m, 1H), 4.14 (s, 3H), 6.69 (s, 1H), 7.45 (s, 1H), 7.87 (s, 1H). LC/MS (m/z): calcd. for C21H26N6S (M+H)+: 395.6; found: 395.2.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07612067B2 |
|---|
| Source dataset | uspto-grants-2009_11 |
|---|
| ORD ID | ord-ada5207c826042f281dfba95a16143a5 |
|---|
| Source note | uspto-grants-2009_11 |
|---|